BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 22481276)

  • 1. Do survival rate and serum ion concentrations 10 years after metal-on-metal hip resurfacing provide evidence for continued use?
    Hartmann A; Lützner J; Kirschner S; Witzleb WC; Günther KP
    Clin Orthop Relat Res; 2012 Nov; 470(11):3118-26. PubMed ID: 22481276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are Females at Greater Risk for Revision Surgery After Hip Resurfacing Arthroplasty With the Articular Surface Replacement Prosthesis?
    Donahue GS; Lindgren V; Galea VP; Madanat R; Muratoglu O; Malchau H
    Clin Orthop Relat Res; 2016 Oct; 474(10):2257-65. PubMed ID: 27121872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent femoral neck osteolysis with Birmingham mid-head resection resurfacing arthroplasty in young patients.
    Asaad A; Hart A; Khoo MM; Ilo K; Schaller G; Black JD; Muirhead-Allwood S
    Clin Orthop Relat Res; 2015 Dec; 473(12):3770-8. PubMed ID: 25981716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metal ion levels from well-functioning Birmingham Hip Resurfacings decline significantly at ten years.
    Van Der Straeten C; Van Quickenborne D; De Roest B; Calistri A; Victor J; De Smet K
    Bone Joint J; 2013 Oct; 95-B(10):1332-8. PubMed ID: 24078528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The withdrawn ASR™ THA and hip resurfacing systems: how have our patients fared over 1 to 6 years?
    Hug KT; Watters TS; Vail TP; Bolognesi MP
    Clin Orthop Relat Res; 2013 Feb; 471(2):430-8. PubMed ID: 22926492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Our Experience with ICON Hip Resurfacing System].
    Trč T; Šťastný E; Kopečný Z; Kos P; Přidal J; Havlas V
    Acta Chir Orthop Traumatol Cech; 2022; 89(5):323-331. PubMed ID: 36322031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High metal ion levels after use of the ASR™ device correlate with development of pseudotumors and T cell activation.
    Hailer NP; Bengtsson M; Lundberg C; Milbrink J
    Clin Orthop Relat Res; 2014 Mar; 472(3):953-61. PubMed ID: 24081666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance of Patients with Metal-on-Metal Hip Resurfacing and Total Hip Prostheses: A Prospective Cohort Study to Investigate the Relationship Between Blood Metal Ion Levels and Implant Failure.
    Hart AJ; Sabah SA; Sampson B; Skinner JA; Powell JJ; Palla L; Pajamäki KJ; Puolakka T; Reito A; Eskelinen A
    J Bone Joint Surg Am; 2014 Jul; 96(13):1091-1099. PubMed ID: 24990974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing the failure rate of hip resurfacing in dysplasia patients: a retrospective analysis of 363 cases.
    Gaillard MD; Gross TP
    BMC Musculoskelet Disord; 2016 Jun; 17():251. PubMed ID: 27267594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poor Survivorship and Frequent Complications at a Median of 10 Years After Metal-on-Metal Hip Resurfacing Revision.
    Matharu GS; Pandit HG; Murray DW
    Clin Orthop Relat Res; 2017 Feb; 475(2):304-314. PubMed ID: 27188835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical variables influence metal ion levels after hip resurfacing.
    Desy NM; Bergeron SG; Petit A; Huk OL; Antoniou J
    Clin Orthop Relat Res; 2011 Jun; 469(6):1635-41. PubMed ID: 20972653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does ion release differ between hip resurfacing and metal-on-metal THA?
    Moroni A; Savarino L; Cadossi M; Baldini N; Giannini S
    Clin Orthop Relat Res; 2008 Mar; 466(3):700-7. PubMed ID: 18196364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metal-on-Metal Total Hip Resurfacing Arthroplasty: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(4):1-57. PubMed ID: 23074495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of bearing wear, whole blood and synovial fluid metal ion concentrations and histopathological findings in patients with failed ASR hip resurfacings.
    Lehtovirta L; Reito A; Parkkinen J; Hothi H; Henckel J; Hart A; Eskelinen A
    BMC Musculoskelet Disord; 2017 Dec; 18(1):523. PubMed ID: 29228956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 2012 Otto Aufranc Award: The interpretation of metal ion levels in unilateral and bilateral hip resurfacing.
    Van Der Straeten C; Grammatopoulos G; Gill HS; Calistri A; Campbell P; De Smet KA
    Clin Orthop Relat Res; 2013 Feb; 471(2):377-85. PubMed ID: 22930211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High revision rate at 5 years after hip resurfacing with the Durom implant.
    Naal FD; Pilz R; Munzinger U; Hersche O; Leunig M
    Clin Orthop Relat Res; 2011 Sep; 469(9):2598-604. PubMed ID: 21279484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do ion levels in hip resurfacing differ from metal-on-metal THA at midterm?
    Moroni A; Savarino L; Hoque M; Cadossi M; Baldini N
    Clin Orthop Relat Res; 2011 Jan; 469(1):180-7. PubMed ID: 20544315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revision of Metal-on-metal Hip Prostheses Results in Marked Reduction of Blood Cobalt and Chromium Ion Concentrations.
    Lainiala O; Reito A; Elo P; Pajamäki J; Puolakka T; Eskelinen A
    Clin Orthop Relat Res; 2015 Jul; 473(7):2305-13. PubMed ID: 25623595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of the First U.S. FDA-Approved Hip Resurfacing Device at 10-Year Follow-up.
    Su EP; Ho H; Bhal V; Housman LR; Masonis JL; Noble JW; Hopper RH; Engh CA
    J Bone Joint Surg Am; 2021 Jul; 103(14):1303-1311. PubMed ID: 33999875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-year serum metal ion levels in minimally invasive total conservative hip resurfacing: preliminary results of a prospective study.
    Tai SM; Millard N; Munir S; Jenabzadeh AR; Walter LR; Walter WL
    ANZ J Surg; 2015 Mar; 85(3):164-8. PubMed ID: 25288230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.